Filing Flows › Pharma-Bio Serv (PBSV) › Stock forecast & fair value
Pharma-Bio Serv (PBSV) stock forecast and price target
Pharma-Bio Serv (PBSV) trades at $0.40. One analyst's price target is $1.55 (+288%).
Pharma-Bio Serv's latest quarter
Pharma-Bio Serv, Q3 FY26: revenue $2.3M (+19% year over year), operating margin -3.1%, net loss $14K, operating cash flow $61K. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for PBSV stock?
One analyst's 12-month target is $1.55, +288% from $0.40. The average rating is none.
Does Pharma-Bio Serv usually beat earnings estimates?
It beat the consensus EPS estimate in 0% of the quarters on record.
Is PBSV stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.